Ceapro Inc V.CZO

Chemicals Specialty Chemicals

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.

TSXV:CZO - Post by User

Ceapro Inc > a second formulation of avenanthramides pills

<< Previous

Bullboard Posts

Next >>

Comment by prophetoffactzon Dec 14, 2022 6:38pm

137 Views

Post# 35172060

RE:RE:RE:RE:a second formulation of avenanthramides pills

"NOTE subsequent to the quarter and expected to receive clearence within 90days.

Well 90days are up you idiot where is the news release?"

90 days is not up. It has only been 75 days subsequent to the end of the quarter.

Hopeforthebest wrote: USED PROPHYLATIC This is what you quoted initially, not the partial edited garbage you just wrote.

"Clinical Trial:

Subsequent to quarter, the Company received an Acknowledgement Letter from Health Canada confirming complete information and material to support a Clinical Trial Application (CTA) for Phase 1/2a study entitled “Ceapro Inc Avenanthramide (AVA): A Double-Blind, Placebo-Controlled, Randomized, Adaptive, First-in-Human Study to Assess Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Oral Doses of Avenanthramide (AvenActive).” A response from Health Canada for clearance to proceed with this study is expected to be received within 90 days."

NOTE subsequent to the quarter and expected to receive clearence within 90days.

Well 90days are up you idiot where is the news release?